CVS Health (CVS) Model Not Broken, Buy on Weakness - Guggenheim
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Crude Inventory Declined 6.4 Million Barrels Last Week
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
Mizuho Recommends Buying CVS (CVS) on Today's Weakness, Driven by Retail
November 8, 2016 8:46 AM ESTMizuho Securities analyst Ann Hynes weighed in on CVS Health (NYSE: CVS) after the company post rare guidance reduction on retail weakness.
Hynes commented, "CVS reported a 3Q beat (adjusted EPS of $1.64 versus consensus $1.57E), but lowered 2016E guidance by 1% at the midpoint. 2017E initial guidance was provided early (usually given in December) and its 10% below our and Street estimates at the mid-point. CVS also provided an updated on its long-term guidance at +10%, which is below current of +10-14% but in-line (or better) than Street expectations given the lack of generic introduction... More
CVS Health (CVS) Q3 Solid But Guidance Well Behind - Leerink
November 8, 2016 8:42 AM ESTLeerink Partners analyst David Larsen weighed in on CVS Health (NYSE: CVS) following solid Q3 results but disappointing guidance which has the stock down 15.3%.
Larsen commented, "This morning CVS reported 3Q:16 earnings. While earnings in the quarter were solid, guidance was disappointing.... More
Walgreens Boots Alliance (WBA) Trades Lower in Sympathy with CVS Health (CVS)
November 8, 2016 7:47 AM ESTWalgreens Boots Alliance (NASDAQ: WBA) was poised to open lower Tuesday morning as shares fell in sympathy with CVS Health (NYSE: CVS).
CVS declined 16% after reporting Q3 results and guidance that disappointed investors.
CVS Health (CVS) Tops Q3 EPS by 7c; Trims, Narrows FY16 EPS Outlook
November 8, 2016 6:56 AM ESTCVS Health (NYSE: CVS) reported Q3 EPS of $1.64, $0.07 better than the analyst estimate of $1.57. Revenue for the quarter came in at $44.6 billion versus the consensus estimate of $45.29 billion.
CVS noted, Adjusted EPS excludes $197 million and $160 million of intangible asset amortization for the three months ended... More
